Value, Pricing & Access Strategy.
Meet the needs of payers, clinicians, and patients.
What we do.
Meet the needs of payers, clinicians and patients with value-driven pricing and market access strategies that deliver access for patients and recognize your organization for its innovation.
We transcend commercial and scientific domains to provide payer landscape and opportunity assessment, strategic value propositions, evidence gap assessment and evidence generation plans, HTA navigation, payer and channel contracting, distribution strategy and beyond.
How we help.
We can help you assess access opportunities and challenges and pursue value-based pricing and quality access across all stages of product development and lifecycle.
We provide true strategic partnership with a relentless focus on your business objectives, leveraging our depth of scientific and commercial expertise, a cross-functional collaborative approach, and agile attitude.
Our world-class Value, Pricing, and Access strategy team provides a holistic set of consultative solutions, including:
- Strategic market access planning and roadmaps
- Pricing strategy and TPP evaluation
- Landscape analysis
- Opportunity assessment
- HTA strategy and submission support
- Strategic value proposition testing
- Evidence gap analysis and generation plans
- Tactical value communications
- Offer, tender, and contracting strategy
- Negotiation guides and playbooks
- Distribution and access services planning
- Patient out-of-pocket cost and access optimization
- Loss-of-exclusivity strategy
Featured case study
Early value insights to drive value definition and evidence needs to produce TrPP.
Regulations in Europe & the US
The Joint Clinical Assessment (JCA)
At Putnam, we specialize in helping you navigate this new landscape with strategic insight and operational excellence. Learn more about our top recommendations for JCA success.
Regulations in Europe & the US
Inflation Reduction Act
Our experts continue to support clients navigate the impacts of the IRA and prepare them for what’s next. What actionable steps can you take to ensure the most optimal path? Read our latest insight.
Latest thinking.
Get the latest insights and perspectives from our experts.
-
Read more
Webinar on the IRA in partnership with BioCentury
Scott Briggs, Principal, joined a live panel of industry experts to discuss the Inflation Reduction Act on March 30th.
-
Read more
Early value insights to drive value definition and evidence need to produce TrPP
The client wanted to understand the key drivers of value for the new treatment for sleep disorders including narcolepsy.
-
Read more
The burden of hospitalizations for COVID-19 in France: A study of all cases in the national insurance claims database in 2020
Our Putnam PHMR colleagues delivered an in-depth analysis on the burden of patient hospitalizations in France as a result of COVID-19.
-
Read more
HTA evidence generation and preparedness for a novel oncology treatment
Our client needed successful HTA evidence packages and submissions to achieve reimbursement across Europe for an innovative oncology treatment.
Get in touch.
Looking to get in touch with an expert or team member?
Tell us how we can help.
Related offerings.
-
Value, Pricing & Access
-
HEOR Evidence Generation
-
Evidence Synthesis & RWE Generation